Table 3.
Secondary outcomes (Mean, SD or %) | Intervention | Control | Net Difference | P value | ||
---|---|---|---|---|---|---|
| ||||||
Pre- Intervention |
Post- Intervention |
Pre- Intervention |
Post- Intervention |
|||
Total | N=1,095 | N=991 | ||||
Use of aspirin in the past month^,#, % | 6.0 | 20.6 | 4.7 | 2.2 | 17.1 | <0.001 |
Mean systolic blood pressure#, mmHg | 161.3, 29.6 | 149.5, 26.1 | 161.4, 27.8 | 152.3, 27.2 | −2.7 | 0.04 |
Current smoker, % | 36.7 | 37.5 | 37.5 | 36.3 | 2.0 | 0.42 |
Awareness of harms of high salt diet#, % | 46.9 | 61.9 | 36.8 | 60.0 | −8.2 | 0.06 |
Receiving monthly follow-up, % | 20.2 | 40.6 | 16.2 | 20.6 | 16.0 | <0.001 |
Hospitalization during the past year, % | 14.5 | 11.7 | 11.4 | 12.5 | −3.9 | 0.09 |
China | N=557 | N=479 | ||||
Use of aspirin in the past month^, % | 7.0 | 26.8 | 5.6 | 0.9 | 24.5 | <0.001 |
Mean systolic blood pressure, mmHg | 166.2, 30.8 | 153.6, 26.8 | 164.4, 28.8 | 155.9, 28.3 | −4.1 | 0.006 |
Current smoker, % | 37.5 | 39.5 | 36.2 | 36.2 | 2.0 | 0.58 |
Awareness of harms of high salt diet, % | 64.1 | 91.6 | 52.9 | 79.8 | 0.6 | 0.03 |
Receiving monthly follow-up, % | 27.3 | 45.2 | 28.1 | 29.5 | 16.5 | <0.001 |
Hospitalization during the past year, % | 15.3 | 10.9 | 12.5 | 13.7 | −5.6 | 0.07 |
India | N=538 | N=512 | ||||
Use of aspirin in the past month^, % | 5.0 | 14.5 | 3.7 | 3.4 | 9.8 | 0.003 |
Mean systolic blood pressure, mmHg | 156.2, 27.4 | 145.6, 25.0 | 158.5, 26.5 | 148.7, 25.7 | −0.8 | 0.83 |
Current smoker, % | 35.9 | 35.5 | 38.7 | 36.3 | 2.0 | 0.22 |
Awareness of harms of high salt diet, % | 29.1 | 32.4 | 21.4 | 40.5 | −15.8 | <0.001 |
Receiving monthly follow-up, % | 12.8 | 36.2 | 5.1 | 11.7 | 16.8 | 0.20 |
Hospitalization during the past year, % | 13.6 | 12.6 | 10.4 | 11.3 | −1.9 | 0.53 |
“Use of aspirin” is defined as patient-reported use of community-health worker-prescribed aspirin for ≥ 25 days in the past month.
A significant interaction between China and India was found for this variable.